Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Hymovis is a formulation containing Sodium Hyaluronate Hexadecylamide, designed to provide relief and support to joints. Sodium Hyaluronate, a naturally occurring substance found in the human body, is primarily present in the synovial fluid of joints, eyes, and skin. Its primary function is to act as a cushion and lubricant in the joints and other tissues. When combined with Hexadecylamide, the efficacy and longevity of Sodium Hyaluronate are enhanced, offering longer-lasting relief and improved joint mobility.
Hymovis is ideal for individuals experiencing joint discomfort, reduced mobility, or those seeking to maintain optimal joint health. Its unique formulation ensures that the joints remain lubricated, reducing friction and promoting smoother movement. Before you buy Hymovis, it is crucial to talk to your healthcare provider about its effectiveness, potential side effects and Hymovis injection price.
Fact Table | |
---|---|
Formula | C28H44N2NaO23 (base molecule of Sodium Hyaluronate) |
License | Approved by FDA (specific approval date not available) |
Bioavailability | Not applicable (administered via intra-articular injection) |
Legal Status | Prescription drug |
Chemical Name | Sodium Hyaluronate Hexadecylamide |
Elimination Half-life | Not specifically defined, varies by injection site dynamics |
Dosage (Strength) | Typically administered as 24 mg/3 mL per injection |
Pregnancy Advice | Insufficient data for safety assessment; consult healthcare provider |
Brands | Hymovis |
Protein Binding | Not applicable |
PubChem CID | Not available specific to hexadecylamide derivative |
MedlinePlus Number | Not listed |
ChEBI ID | Not available specific to hexadecylamide derivative |
ATC Code | Not listed specific to hexadecylamide derivative |
DrugBank ID | Not available specific to hexadecylamide derivative |
KEGG ID | Not listed |
Routes of Administration | Intra-articular injection |
Hymovis injection is to be administered by a qualified healthcare professional. Ensure the area of injection is clean and free from any signs of infection.
Refrain from strenuous activities for 48 hours post-injection. Mild exercise like walking can be resumed after 24 hours.
Store Hymovis in a cool, dry place, away from direct sunlight. Do not freeze.
The active ingredient in Hymovis is Sodium Hyaluronate Hexadecylamide.
Do not use Hymovis if you have a known allergy to Sodium Hyaluronate or any of the ingredients listed.
Avoid using Hymovis if there is an active infection or skin disease at the injection site.
Pregnant or breastfeeding women should consult their healthcare provider before considering Hymovis treatment.
Hymovis is not recommended for individuals under the age of 18.
If you experience any unusual symptoms post-injection, such as increased pain, swelling, or redness, contact your healthcare provider immediately.
Let your healthcare professional know about all the medicines you're on now. It is recommended to wait at least two weeks between receiving Hymovis and any other joint injection treatments.
Common side effects of Hymovis include:
Rare side effects include:
Remember, these are not exhaustive lists, and it's important to consult with a healthcare professional for personalized advice and guidance. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
How long does Hymovis last?
Hymovis effects can last for about six months, but results might differ for each person.
How long does it take for Hymovis to work?
Most people feel better within a few weeks after the injection, with the best results typically seen around 8 weeks.
What is Hymovis made from?
Hymovis is formulated from Sodium Hyaluronate Hexadecylamide, a specialized derivative of hyaluronic acid, crafted to replicate the knee's natural synovial fluid.
Are hyaluronic acid injections safe for knees?
Generally, hyaluronic acid injections like Hymovis are deemed safe for knee osteoarthritis treatment. They are designed to mirror natural joint fluid. However, potential risks exist, so a thorough discussion with a healthcare provider is essential.
How often can you get Hymovis injections?
Usually, two injections are given a week apart. Depending on how a person reacts and the seriousness of their osteoarthritis, more injections may be suggested by a doctor.